EOX Dose Modifications from Phase I Study of Epigenetic Priming with Azacitidine Prior to Standard Neoadjuvant Chemotherapy for Patients with Resectable Gastric and Esophageal Adenocarcinoma: Evidence of Tumor Hypomethylation as an Indicator of Major Histopathologic Response

Autor: Joseph M. Scandura, Pouneh Kermani, Agnes Viale, Daoqi You, Romae Palmer, Paul J. Christos, Rhonda Yantiss, Andrew Schreiner, Michael Lieberman, Nasser Altorki, Elizabeta Popa, Allyson Ocean, Kelsey Klute, Manish A. Shah, Bryan J. Schneider
Rok vydání: 2023
DOI: 10.1158/1078-0432.22462365.v1
Popis: EOX Dose Modifications
Databáze: OpenAIRE